Live Chat ×
Skip to main content

Thyroid Histopathology, Cytology and Molecular Diagnosis in the NIFTP Era

Original release date: October 21, 2017
Access expires: October 20, 2020, at 11:59 PM Pacific Time

Course Description
Especially valuable to surgical pathologists and cytopathologists alike, the latest updates on noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) will help ensure that a subset of indolent thyroid tumors is managed more conservatively and spares patients the anxiety of a cancer diagnosis. The activity will help pathologists and cytopathologists minimize malignant diagnoses on cytology associated with a final diagnosis of NIFTP and identify potential NIFTPs in indeterminate aspirates to promote conservative surgical management.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training.

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Learn to accurately render a diagnosis of NIFTP and recognize NIFTP mimics
  • Learn how NIFTP affects the risk of malignancy for Bethesda diagnostic categories
  • Learn how to diagnose potential NIFTPs on cytology within the framework of the Bethesda system
  • Learn how NIFTP will affect the results of molecular testing of thyroid nodules

Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 3 SAM/Part II credit hours.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Justine A. Barletta, M.D. Jeffrey Krane, M.D., Ph.D.

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.

Not A Member? Click Here